Primary HIV infection - A public health opportunity

American Journal of Public Health

Volumn 87, Issue 12, 1997, Pages 1928-1930

  Cates Jr , Willard ^a   Chesney, Margaret A ^b   Cohen, Myron S ^c  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE TRANSMISSION; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; REVIEW; VIRUS INFECTION; VIRUS TRANSMISSION;

EID: 0031442425     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.87.12.1928     Document Type: Review

References (26)

1. Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunologic mechanisms of HIV infection. Ann Intern Med. 1996;124:654-663.
2. Quinn TC. Acute primary HIV infection. JAMA. 1997;278:58-62.
3. Kinloch-de Loës S, Hirschel BJ, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med. 1995;333:408-413.
4. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA, Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167-1170.
5. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immune Defic Syndr. 1997;14:249-258.
6. Dickover RE, Garratty EM, Hemman SA, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 1996;275:599-605.
7. Busch MP, Operskalaki EA, Mosley JW, et al., for the Transfusion Safety Study Group. Factors influencing HIV-1 transmission by blood transfusion. J infect Dis. 1996;174:26-33.
8. Lee T-H, Sakahara N, Fiebig E, Busch MP, O'Brien TR, Hemman SA. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12:427-428. Letter.
9. Vernazza PL, Gilliam BL, Dyer J, et al. Quantitation of HIV in semen: correlation with antiviral treatment and immune status. AIDS. 1997;11:987-993.
10. Rasheed S. Zhiliang L, Xu D, Kovacs A. Presence of cell-free human immunodeficiency virus in cervical vaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women. Am J Obstet Gynecol. 1996;175:122-130.
11. Liuzzi G, Chirianni A, Clementi M, et al. Analysis of HIV 1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS. 1996;10:F51-F56.
12. Dyer JR, Gilliam BL, Eron JJ, Fiscus SA, Vernazza P, Cohen MS. Effects of disease stage and CD4+ lymphocyte count on shedding of HIV-1 in semen. In: Program and Abstracts of the XI International Conference on AIDS; July 7-12, 1996; Vancouver, BC, Canada. Abstract We.C. 335.
13. Catania JA, Moskowitz JT, Ruiz M, Cleland J. A review of national AIDS-related behavioral surveys. AIDS. 1996;20(suppl):S183-S190.
14. Morris M, Kretzschmar M. Concurrent partnerships and transmission dynamics in networks. Soc Networks. 1995;17:299-318.
15. St. Louis ME, Wasserheit JN, Gayle HD. Editorial: Janus considers the HIV pandemic-harnessing recent advances to enhance AIDS prevention. Am J Public Health. 1997;87:10-12.
16. Garnett GP, Anderson RM. Strategies for limiting the spread of HIV in developing countries: conclusions based on studies of the transmission dynamics of the virus. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:500-513.
17. Edlin BR, Irwin KL, Panique S, et al. Intersecting epidemics: crack cocaine use and HIV infection among inner city young adults. N Engl J Med. 1994;331:1422-1427.
18. Wiwat R, Hanenberg R. The 100 percent condom program in Thailand. AIDS. 1996;10:1-7.
19. Cates W Jr, Hinman AR. AIDS and absolutism: the demand for perfection in prevention. N Engl J Med. 1992;327:492-494.
20. Wortley PM, Chu SY, Diaz T, et al. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? AIDS. 1995;9:487-492.
21. Wasserheit JN. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis. 1992;19:61-77.
22. Aral SO, Holmes KK, Padian NS, Cates W Jr. Overview: individual and population approaches to the epidemology and prevention of sexually transmitted diseases and human immunodeficiency virus infection. J Infect Dis. 1996;174(suppl 2):S127-S133.
23. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995;346:530-536.
24. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet. 1997;349:1868-1873.
25. Wawer MJ, Sewankambo NK, Gray RH, et al. Community-based trial of mass STD treatment for HIV control, Rakai, Uganda: preliminary data on STD declines. In: Program and Abstracts of the XI International Conference on AIDS; July 7-12, 1996; Vancouver, BC, Canada. Abstract .Mo.C.443.
26. Koopman JS, Little RJ. Assessing HIV vaccine effects. Am J Epidemiol. 1995;142:1113-1120.